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1. Introduction 
A number of studies have empIoyed ruthenium red, 
a potent inhibitor of mitochondrial Ca2’-transport, to 
distinguish lllitochondrial (i.e.. rutheniu~n red-sen- 
sitive) from non-mitochondrial (i.e., ruthenium red- 
insensitive) Ca’+-transport systems in subcellular frac- 
tions of rat liver [l-3]. 
We have described a subcellular fraction of rat liver 
having a ruthenium red-insensitive ta*‘-transport sys- 
tem which was responsive to the action of glucagon 
[3,4]. This fraction was obtained by sedimenting the 
postmitochondrial supernatant in buffered iso-osmotic 
sucrose at 34 800 X g for 20 min. Glucagon en~lanced 
the Ca’+-transport activity in this fraction when the 
hormone was administered by intraperitoneal injec- 
tion to the whole animal or incubated with rat hepa- 
tocytes in vitro prior to subcellular fractionation. 
In the study employing rat hepatocytes the action 
of glucagon was mimicked by dibutyryl 3’,5’-cyclic 
adenosine monophosphate (CAMP) [4]. This suggested 
that glucagon may stimulate Caz+-transport in tile 
intermediate fraction by a mechanism involving the 
action of CAMP, and raised the possibility that Ca’+- 
transport by the endoplasmic-rich intermediate frac- 
tion of rat liver may be controlled by a pbosphoryla- 
tion-depbosphorylation cycle similar to that which 
regulates Ca2*-transport by the sarcoplasn~lc retic- 
ulum of contractile tissues [S,SJ. In view of the 
potential involvement of such a mechanism in the 
control ofintracellular Ca2+ in the liver, these findings 
were examined in more detail. 
This study shows that Ca2*-transport activity in 
the s~lbcellular fraction described was enhanced by 
92 
prior incubation of hepatocytes with CAMP analogues 
or with various agents which elevate the CAMP con- 
centration. Ca2+-transport activity was also stimulated 
in this fraction following incubation in vitro with 
50 pM CAMP, 250 PM ATP and small anlounis of a 
rat liver supernatant fraction. 
2. Experimental 
Male Wistar rats (200-250 g) fed ad libitum were 
used in all experiments. The methods of preparation 
and i~lcubatiorl of hepatocytes were those detailed in 
[71. 
2.2. Preparation of membrane fractions 
At the conclusion of the incubation, hepatocytes 
were collected by brief centrifugation in a bench cen- 
trifuge (500 X g for 1 min), resuspended in ice-cold 
5 mM Hepes buffer (pH 6.8) and homogenized by 
hand using a 40 ml glass Dounce llomogenizer (20 
strokes). The homogenate was resuspended in ice-cold 
250 mM sucrose, 5 mM Hepes buffer (pH 6.8) plus 
0.5 mM EGTA and centrifuged at I2 000 X g for 
10 min in a Sorvall KC-2B refrigerated centrifuge (SS- 
34 rotor) to remove cell debris, nuclei and the bulk of 
the mitochondria. The supernatant fraction was cen- 
trifuged at 34 800 X g for 20 min. This fraction has 
been designated as the ‘intermediate fraction’. The 
pellet obtained was resuspended in an appropriate 
volume of 250 mM sucrose, 1 mM dithiothreitol plus 
5 mM Hepes (pH 6.8). 
In experinlents where the interlnediate fraction 
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was prepared from rat liver rather than from hepato- 
cytes the preparative procedure was varied as follows. 
The livers from rats killed by cervical dislocation were 
rapidly removed and placed in ice-cold isolation medi- 
um containing 250 mM sucrose, 5 mM Hepes buffer 
(pH 6.8) plus 0.5 mM EGTA. They were minced with 
scissors and homogenized by 2 passes with a glass- 
Teflon tissue disintegrator (A. H. Thomas Co., Phila- 
delphia, PA, size C) which was motor-driven at 900 
rev.fmin. The resulting suspension was made up to 
80 ml with isolation medium and centrifuged at 
1085 X g for 5 min in a Sorvall RC-2B centrifuge (SS- 
34 rotor). The supernat~t was centrifuged for a 
further 5 min at 4340 X g. The resultant supernatant 
fraction was centrifuged for a further 10 min at 
7710 X g and the supernatant obtained was subjected 
to a final 20 min period of centrifugation at 34 800 X 
g. The pellet obtained from this final centrifugation 
step was resuspended in an appropriate volume of 
100 mM KC1 containing 5 mM sucrose, 5 mM Hepes 
buffer (pH 6.8) and I mM dithiothreitol. 
2.3. Protein determination 
Protein content was measured by the method in 
[S] with crystalline bovine serum albumin as standard. 
2.4.3’,5’-Cyclic AMP determination 
Following incubation of hepatocytes for 5 min 
with various agents (see section 3) cells were col- 
lected by centrifugation in a Beckman microfuge 
(5--10 s). The supernatants were rapidly removed 
and the cell pellets dispersed in 0.5 ml distilled water 
maintained at $5--9S*C. The samples were boiled for 
a further IO min with intermittent agitation to aid 
dispersal of cellular debris. The bulk of the dena- 
tured proteins were pelleted by centrifugation 
(Beckman microfuge, 4 min) and the CAMP content 
of the supernatant was measured by radioimmuno- 
assay [9]. The procedure was validated in the manner 
discussed [9]. The specificity of the assay for CAMP 
was such that purification of samples was not 
required. 
2.5. Ca~ci~rn transport 
Uptake of radioactive Ca2+ was measured by mem- 
brane filtration employing a modi~cation [2] of the 
method in [IO], Transport assays were performed at 
37’C in the following incubation medium: 100 mM 
KCl, 20 mM Hepes buffer (ptf 6.8), 5 mM MgCla, 
3.3 mM ammonium oxalate, 2.5 ,uM ruthenium red 
and 0.3-0.5 mg protein in 1.5 ml final reaction vol. 
After a preincubation time of 2 min, 5 mM ATP 
(pH 6.8) was added and the assay was initiated by the 
addition of 5 ~1 10 mM 4sCa2’. At specified time 
intervals a 100 ~1 sample of the reaction medium was 
removed and filtered through a membrane filter 
(0.45 ,um porosity) prewashed with 250 mM sucrose 
plus 5 mM Hepes. The membrane filters were washed 
again to remove non-sequestered 45Ca2’, then dis- 
solved in 10 ml scintillant (6 g butyl-PBD in 400 ml 
2-me~oxyethanol plus 600 ml toluene). Radioactiv- 
ity retained by the filters was measured by liquid 
scintillation spectrometry. The specific activity of the 
radioisotope in each incubation was determined by 
counting an unfiftered 100 ~1 sample. 
2.6. ~~ate~a~s 
45CaC12 was obtained from the Radiochenli~l 
Centre, Amersham. Rut~lenium red was purchased 
from Sigma Chemical Co,, St Louis, MO and recrystal- 
lized by the method in [l 11. Nucleotides were from 
Boehringer, Mannlleim GmbH, collagenase (type B) 
was obtained from Worthington Biochemical Corp. 
(Freehold, NJ). Membrane filters (0.45 pm porosity) 
were obtained from the Gelman Instr. Co., Ann 
Arbor, MI. Glucagon (crystalline), theophyllinc, 3- 
isobutyl-1 -methylxanthine (IBMX) dibutyryl CAMP 
and 8-bromo-CAMP (crystalline) were acquired from 
Sigma Chemical Co. Crystaihne beef insulin was from 
Commonwealth Serum Labs. (Parkville, VIC). Roche 
compound Ro-20-1724 was the kind gift of Dr H. 
Sheppard, Roche Chemical Co. All other materials 
were of analytical reagent grade. 
3. Results 
Ruthenium red-insensitive Ca’+-transport by sub- 
cellular fractions of rat liver was determined by ini- 
tial rate measurements as in ]2,3]. In earlier studies, 
Ca2+-transport activity by the intermediate fraction 
isolated either from rat liver or from rat hepatocytes 
was shown to be enhanced by pretreatment of the 
whole animal or cell suspension with glucagon [3,4]. 
When hepatocytes were employed, glucagon was 
reported to be maximally effective following exposure 
of the cells to the hormone for 20 min. This same 
exposure time was therefore also used in the present 
study where the effects of a number of agents on the 
Ca2”-transport ability of the intermediate fraction 
were investigated. Data in table 1 show that glucagon 
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Table 1 
Effect of agents on Ca**-transport by the intermediate fraction and on hepatocyte 
CAMP concentration 
---~ 
Addition Relative rate of Relative cAMP 
Ca2+-transport concentration 
--.._-.-------.----- . ..- -..~--____ ____-_ 
None 100 100 
Insulin 125 t 22 (6) 115 i 9(3) 
Glucagon 1781 9 (8)” 375 + 41 @)a 
Giucagon + insulin 115 i- 13 (6) 347 + 23 (s)a 
Theophylline 157 f 12 (6)” 146 -f 14 (4)a 
3-lsobutyl-l-Illethyl- 
xanthine 148 i 16 (4)a 
Ro-20-1724 153 + 13 (4)” 
8-Bromo-cAMP 163 + 11 (3)a 
Dibutyryi~A~~P 171 ‘r 19 (6)a 
-- -__ .-_.-.---___--_-_-..__-~.- 
a p < 0.01 compared to no addition 
204 + 38 (3)a 
187 i 18 (4)a 
_ 
_ 
_~“~. .- 
Hepatocytes were incubated at 37’C in Krebs-Henseleit bicarbonate buffer with 
the additions shown. Incubations were performed for 5 min when the CAMP 
concentration was determined or for 20 min when Ca*+-transport was determined 
in the intermediate fraction subsequently isolated. The following agents were 
added as indicated: glucagon (2 X lo-” M); insulin (I mu/ml); theophylline 
(8 X 10m4 M); 3-isobutyl-1-~letbylxanthine (5 X 10e4 M); Ro-20-1724 (8 X IOF 
M); 8-brorno-cAMP (5 X 1 O^” M); dibutyryl CAMP (5 X IO-“ M). In the absence 
of further additions the initial rate of Ca*+-transport was 6.4 t 0.6 nmol . min-* . 
mg protein-’ (II = 8) and the CAMP concentration was 0.53 I 0.04 nmol/g cell 
wet wt (?r = 10). Results were calculated retative to these respective control values 
and expressed as the mean t SEM for the no. expt indicated in parentheses 
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entranced the initial rate of Ca2”-transport in the sub- 
sequently isolated inter~ltediate fraction by nearly 
80%. Insulin alone was without effect, but com- 
pletely abolished the stimuiatory effect of glucagon 
when both hormones were added siiltultaneously. 
These results essentially col~~rl~led our findings in 
[4]. Data shown in table 1 also denlonstrate that 
analogues of cAMP (dibutyryl-CAMP and %bromo- 
cAMP) and agents which elevate cAMP concentration 
by inhibition of cyclic nucleotide phosphodiesterase 
activity (theophylline, 3-isobutyl-1 -1llethylxanthine 
(IBM) and Ro-20-1724) all increased, by 40.-7076, 
Ca*+-transport in the intermediate fraction. 
The concentration of CAMP was also determined 
in a parallel series of experiments where cells were 
exposed to the various agents for 5 min prior to 
CAMP determination. Wepatocyte CAMP concentra- 
tions were increased by almost 300% following treat- 
ment with glucagon and by 50--loo%] after exposure 
to theophyllilte, IBMX or Ro-20-1724 (table 1). In 
contrast, insulin had no significant effect on CAMP 
concentrations either under control conditions or 
when levels of the cyclic nucleotide were elevated in 
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the presence of glucagon. 
Possible effects of CAMP on C’a2+-transport activity 
by the intermediate fraction in vitro were also exam- 
ined and the results shown in fig.1 and 2. Preincubation 
of the il~tern~ediate fraction with 250 $vl ATP and 
50 @M CAMP for 10 min at 30°C had no significant 
effect on the initial rate of Ca”-uptake subsequently 
determined (fig.1). Inclusion of purified protein 
kinase (beef heart. 0.1 mg/ml) in the preir~cubatio~l 
mixture was also without effect (results not shown) 
whereas the inclusion of a rat liver supernatant frac- 
tion (-3 mg protein~ml) increased the initial rate of 
Ca’+-transport by -40% (fig.1). The rat liver super- 
natant fraction was ineffective in the absence of 
added CAMP (fig.l,2). The time course of activation 
of Ca”-transport following preincubation of the 
intermediate fraction with ATP, cAMP and super- 
natant fraction is shown in fig.2. Stimulation of Ca2+- 
transport occurred between 5--10 min of preincuba- 
tion and was maximal following a IO min preincuba- 
tion period. At later times both basal and stimulated 
rates of Ca2’-transport declined, presumably reflecting 
instability of the preparation under these conditions. 
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u” TIME (min) 
Fig.1. The in vitro effect of dibutyryi CAMP on the rate of 
ruthenium red-insensitive Ca*+-transport in the intermediate 
fraction isolated from rat liver. The intermediate fraction was 
prepared as in section 2 and preincubated with 250 I.IM ATP 
at 30°C in the presence of both dibutyryl-CAMP (5 X 10m5 M) 
and supernatant fraction (-3 mg protein/mg) for 10 min. For 
some experiments dibutyryl-cAMP was omitted from the 
preincubation mixture, and for others the supematant frac- 
tion was omitted. Results shown are mean of 3 separate expt. 
(*) Dibutyryl-CAMP (5 X lo-’ M) and supernatant fraction 
both present in the preincubation step. (0) DibutyrylcAMP 
omitted from the preincubation mixture. (a) Supernatant 
fraction omitted from the preincubation mixture. 
4. Discussion 
The experiments described here confirm our earlier 
finding that exposure of rat hepatocytes to glucagon 
enhances ruthenium red-insensitive Ca’+-transport in 
the intermediate fraction subsequently isotated from 
the cells [4]. From the data presented it is also evident 
that a similar stimulation of Ca”-transport occurs fol- 
lowing exposure of hepatocytes to theophylline, 
IBMX or Ro-20-1724 (table 1). These agents were 
also shown to elevate hepatocyt~ CAMP concentra- 
tions within 5 min. In addition, analogues of CAMP, 
dibutyryl cAMP and 8-bromo-CAMP (a potent activa- 
tor of protein kinase [12]), stimulated Ca2~-transport 
activity by the intermediate fraction when added to 
hepatocyte suspensions prior to subcellular fraction- 
ation. Moreover, under the conditions in fig.1, the 
Ca2’-transport ability of the intermediate fraction was 
stimulated directly by incubation in vitro with CAMP, 
ATP and the sup~rI~atant fraction. Taken together, 
a 
IY 
I- 2 
r 
0 20 40 
rJ 
U PREINCUBATION TIME (min) 
Fig.2 Time course of the in vitro effect of dibutyryl-CAMP 
on the rate of ruthenium red-insensitive Ca*+-transport in the 
~termediate fraction from rat liver. The intermediate frac- 
tion was prepared as in section 2 and preincubated with ATP, 
dibutyryl-CAMP and supernatant fraction as in fig.1. The 
preincubation time was varied as shown. The Ca2+-uptake 
assay was initiated as in section 2. Results shown are repre- 
sentative of 3 identical expt. (*) Dibutyryl CAMP (5 X 10V5 
M) and supernatant fraction both present in the preincuba- 
tion step. (o) Dibutyryl CAMP omitted from the preincuba- 
tion mixture. (a) Supernatant fraction omitted from the 
preincubation mixture. 
these data suggest hat CAMP may stimulate Ca”- 
transport by the intermediate fraction of rat liver. 
It is now well established that a CAMP-dependent 
phosphorylation mechanism operates to control Ca2+- 
transport in sarcoplasmic reticulum [5,6]. The pres- 
ent data are consistent with the hypothesis that a 
similar mechanism may operate to control the trans- 
port of Ca2* by the intermediate fraction of rat liver. 
An increase in CAMP may activate a CAMP-dependent 
protein kinase, iyhich in turn would phosphorylate a 
protein component of the vesicular membranes in 
the intermediate fraction, thereby activating the Ca’+- 
transport system. The protein component may be the 
‘Ca’+-transporter’ itself or may be similar to the phos- 
pholamban component known to be involved in the 
mechanism described for the sarcoplasmic reticulum 
15,6]. 
The data presented in this study indicate that insu- 
lin may decrease glucdgon-stimulated rates of Ca2+- 
transport in the intermediate fraction by a mecha- 
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nism independent of changes in CAMP concentration. 
Such an effect of insulin may be related to the hor- 
mone’s ability to promote protein dephospborylation, 
presumably through the action of protein phospha- 
tases [13,14]. 
A further interesting finding in the present study 
was the observation that CAMP stimulated Ca*+-trans- 
port by the intermediate fraction in vitro only when 
a small amount of rat liver supernatant fraction was 
also present. This apparent requirement for the rat 
liver supernatant fraction may simply reflect the dis- 
tribution of the appropriate protein kinase in the dif- 
ferent subcellular fractions with the enzyme presum- 
ably being present in the supernatant fraction but vir- 
tually absent in the intermediate fraction. In this 
regard it has been observed that the endogenous 
CAMP-dependent protein kinase of sarcoplasmic retic- 
ulum was rapidly depleted during vesicle preparation 
[ 151. The finding that purified beef heart protein 
kinase was ineffective when substituted for rat liver 
supernatant fraction may indicate a high degree of 
species specificity for the enzyme. Other examples of 
species-specific protein kinase have been reported 
[16]. On the other hand, it is possible that the rat liver 
supernatant fraction contained some other factor 
required for Ca’+-transport activation such as calmo- 
dulin. Maximal stimulation of Ca*+-transport in sar- 
coplasmic reticulum may only occur following phos- 
phorylation of separate sites on the vesicular mem- 
branes catalyzed by CAMP-dependent and Ca*‘/cal- 
modulin-dependent protein kinases, respectively [ 1.51. 
Finally, recent observations suggest a stimulatory 
effect of glucagon and CAMP on the uptake and reten- 
tion of Ca” by rat liver mitochondria ([ 171, W. M. T., 
F. L. B., unpublished). Thus a CAMP-dependent form 
of regulation of Ca’+-transport by the endoplasmic- 
rich intermediate fraction of rat liver, may be part of 
a coordinate alteration of intracellular Ca”-levels and 
this in turn may be an integral part of the metabolic 
effects of glucagon in liver. 
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